MOSCOW, April 19 Russia's government commission
on foreign investment has rejected U.S. Abbott Laboratories'
plan to buy Russian pharmaceutical producer Petrovax,
the head of the Russian antitrust regulator said on Friday.
"The commission has reviewed the question about the sale to
U.S. company Abbott of Petrovax Pharm. As a result of very
lengthy discussion the U.S. company was denied to make this
deal," Igor Artemyev, head of the Federal Anti-Monopoly Service
(FAS), told reporters.
Abbott Laboratories filed for permission to buy the Russian
vaccine developer and producer last year.
Abbott Laboratories spokeswoman Irina Gushchina said the
company had not received any official information regarding the
state of its application.